Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2019-12-27 Legal Proceedings Report
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in Firstline DLBCL (news with additional features)
Legal Proceedings Report Classification · 1% confidence The document is a news release dated December 27, 2019, originating from MorphoSys AG, disseminated via DGAP (a service of EQS Group AG). The content details the dosing of the first patient in a Phase 1b clinical study for the drug tafasitamab in DLBCL. This type of announcement, focusing on clinical trial progress, is typically classified as a general corporate/regulatory announcement rather than a specific financial report (like 10-K, IR, or ER). Since it is a specific corporate update disseminated through a regulatory news service (DGAP), and it doesn't fit the definitions for AGM-R, 10-K, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS, the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2019-12-27 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in voting rights percentages (crossing a threshold) held by BlackRock, Inc. in MorphoSys AG, including the breakdown of direct and indirect holdings via shares and instruments. This content directly corresponds to notifications required when major shareholdings change, which aligns with the definition of 'Major Shareholding Notification' (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the detailed disclosure of ownership changes, making MRQ the most precise fit over DVA (which is for results) or RNS (which is a fallback).
2019-12-16 English
Report Publication Announcement 2019
Report Publication Announcement Classification · 1% confidence The document is titled "Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that it is an announcement regarding the disclosure dates for future financial reports (Quarterly/Interim statements) and provides links to where those reports will eventually be found. The document itself is very short (1624 characters) and does not contain the actual financial data or management discussion. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached classifies as a Report Publication Announcement (RPA).
2019-12-12 English
Report Publication Announcement 2019
Report Publication Announcement Classification · 1% confidence The document is a short announcement dated December 12, 2019, titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that it is announcing *when* various financial reports (Annual financial report, Group annual financial report, Group financial report (half-year/Q2)) *will be disclosed* in the future (March/August 2020), providing disclosure dates and links. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of other reports should be classified as a Report Publication Announcement (RPA).
2019-12-12 English
MorphoSys AG: Corporate Calendar 2020 (news with additional features)
Report Publication Announcement Classification · 1% confidence The document is titled "MorphoSys AG: Corporate Calendar 2020" and explicitly lists future dates for financial reporting (Year-End Results, Quarterly Statements, Half-Year Report) and the date for the Annual General Meeting (AGM) on May 27, 2020. Since the primary content is the announcement of the schedule for corporate events, including the AGM date, it relates to future shareholder meetings and corporate planning. While it mentions the AGM date, the document itself is an announcement of the calendar, not the AGM materials (AGM-R) or the proxy statement (DEF 14A/PSI). It is a general corporate announcement detailing future events. Given the specific mention of the AGM date alongside other reporting dates, and the general nature of the announcement, it fits best as a general Regulatory Filing (RNS) or potentially related to AGM planning. However, since it is a forward-looking calendar announcement disseminated via DGAP, RNS is the most appropriate general regulatory filing category, as it doesn't fit the specific definitions for ER, IR, or CT. The mention of the AGM date is secondary to the overall calendar announcement.
2019-12-12 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by BlackRock, Inc. in MorphoSys AG, referencing specific German securities laws (WpHG Articles 40 and 33/34). This content directly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the change in holding percentage, making MRQ more specific than DVA (Declaration of Voting Results & Voting Rights Announcements) which typically reports the *results* of a vote, not the underlying ownership change triggering a regulatory filing.
2019-12-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.